Nucala الاتحاد الأوروبي - الإيطالية - EMA (European Medicines Agency)

nucala

glaxosmithkline trading services - mepolizumab - asma - farmaci per le malattie respiratorie ostruttive, - severe eosinophilic asthmanucala is indicated as an add-on treatment for severe refractory eosinophilic asthma in adults, adolescents and children aged 6 years and older. chronic rhinosinusitis with nasal polyps (crswnp)nucala is indicated as an add-on therapy with intranasal corticosteroids for the treatment of adult patients with severe crswnp for whom therapy with systemic corticosteroids and/or surgery do not provide adequate control. eosinophilic granulomatosis with polyangiitis (egpa)nucala is indicated as an add-on treatment for patients aged 6 years and older with relapsing-remitting or refractory eosinophilic granulomatosis with polyangiitis (egpa). hypereosinophilic syndrome (hes)nucala is indicated as an add-on treatment for adult patients with inadequately controlled hypereosinophilic syndrome without an identifiable non-haematologic secondary cause.

SCALA إيطاليا - الإيطالية - Ministero della Salute

scala

basf italia s.p.a. - pyrimethanil; - sospensione concentrata - 36.7 g i valori indicati sono per 100 g di prodotto. - fungicida

Nucala 100 mg/mL Soluzione iniettabile in penna Preriempita سويسرا - الإيطالية - Swissmedic (Swiss Agency for Therapeutic Products)

nucala 100 mg/ml soluzione iniettabile in penna preriempita

glaxosmithkline ag - mepolizumabum - soluzione iniettabile in penna preriempita - mepolizumabum 100 mg, saccharum, dinatrii phosphas heptahydricus, acidum citricum monohydricum, polysorbatum 80 dinatrii edetas, aqua ad iniectabile q.s. ad solutionem pro 1.0 ml. - eosinophiles asthma, egpa, crswnp, hes - biotechnologika

Nucala 100 mg/mL Soluzione iniettabile in siringa pre-riempita سويسرا - الإيطالية - Swissmedic (Swiss Agency for Therapeutic Products)

nucala 100 mg/ml soluzione iniettabile in siringa pre-riempita

glaxosmithkline ag - mepolizumabum - soluzione iniettabile in siringa pre-riempita - mepolizumabum 100 mg, saccharum, dinatrii phosphas heptahydricus, acidum citricum monohydricum, polysorbatum 80 dinatrii edetas, aqua ad iniectabile q.s. ad solutionem pro 1.0 ml. - eosinophiles asthma, egpa, crswnp, hes - biotechnologika

Nucala 100 mg Polvere per soluzione Iniettabile سويسرا - الإيطالية - Swissmedic (Swiss Agency for Therapeutic Products)

nucala 100 mg polvere per soluzione iniettabile

glaxosmithkline ag - mepolizumabum - polvere per soluzione iniettabile - praeparatio cryodesiccata: mepolizumabum 100 mg, saccharum, dinatrii phosphas heptahydricus corresp. natrium 1.5-2 mg, polysorbatum 80, acidum hydrochloricum q.s. ad ph pro vitro. - zusatztherapie bei schwerem eosinophilem asthma, zusatztherapie bei erwachsenen mit egpa - biotechnologika

CALA PER PALTO TIBIALE إيطاليا - الإيطالية - Ministero della Salute

cala per palto tibiale

zimmer gmbh - strumentario per chirurgia ortopedica - altro